''So once the Phase 3 trial commences, there's a 64% chance DMX takes a drug to market with, lets say a potential A$20B per annum in global revenues?''....
utter nonsense
Where did you suck that figure out of?
Phase 3 clinical study in FSGS in the first half of 2021, page-2
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.5¢ |
Change
0.005(1.11%) |
Mkt cap ! $253.5M | |||
| Open | High | Low | Value | Volume |
| 46.0¢ | 47.3¢ | 44.5¢ | $638.0K | 1.390M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 212789 | 45.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 46.0¢ | 17430 | 2 |
View Market Depth
| Last trade - 16.10pm 21/10/2024 (20 minute delay) ? |
| DXB (ASX) Chart |